Cell Impact AB (publ) reported consolidated and parent earnings results for the third quarter and nine months ended September 30, 2020. For the quarter, on consolidated basis, the company reported net sales of SEK 8.5 million against SEK 3.5 million a year ago. Operating loss was SEK 5.7 million against SEK 9.0 million a year ago. Loss per share, attributable to the shareholders of the parent company was SEK 0.12 against SEK 0.20 a year ago. Loss attributable to the shareholders of the Parent Company was SEK 6.1 million against SEK 9.0 million a year ago. For the nine months, on consolidated basis, the company reported net sales of SEK 20.4 million against SEK 10 million a year ago. Operating loss was SEK 30.7 million against SEK 30.5 million a year ago. Loss per share, attributable to the shareholders of the parent company was SEK 0.66 against SEK 1.06 a year ago. Loss attributable to the shareholders of the Parent Company was SEK 31.5 million against SEK 31.4 million a year ago. For the quarter, on parent basis, the company reported net sales of SEK 8.5 million against SEK 3.5 million a year ago. Operating loss was SEK 5.8 million against SEK 8.9 million a year ago. Loss for the period was SEK 5.8 million against SEK 8.9 million a year ago. For the nine months, on parent basis, the company reported net sales of SEK 20.4 million against SEK 10 million a year ago. Operating loss was SEK 30.8 million against SEK 30.5 million a year ago. Loss for the period was SEK 30.8 million against SEK 31.4 million a year ago.